Literature DB >> 25436075

Myositis ossificans traumatica causing ankylosis of the elbow.

B Kanthimathi1, S Udhaya Shankar1, K Arun Kumar1, V L Narayanan1.   

Abstract

Myositis ossificans traumatica is an unusual complication following a muscle contusion injury. A significantly large myositic mass causing ankylosis of the elbow is even rarer. We report a 13-year-old boy who presented with a 14-month history of a fixed elbow with no movement and a palpable bony mass in the anterior aspect of the elbow. He had sustained significant trauma to the affected limb 1 month prior to onset of symptoms, which was managed by native massage and bandaging for 4 weeks. The clinicoradiological diagnosis was suggestive of myositis ossificans, and the myositic mass was completely excised. Histopathology revealed lamellar bone. The 2-year follow-up showed full function of the affected limb and no signs of recurrence. We report this case of clinical interest due to the unusually large myositic mass.

Entities:  

Keywords:  Ankylosed elbow; Excision; Myositis ossificans

Mesh:

Year:  2014        PMID: 25436075      PMCID: PMC4233230          DOI: 10.4055/cios.2014.6.4.480

Source DB:  PubMed          Journal:  Clin Orthop Surg        ISSN: 2005-291X


  10 in total

1.  Pseudomalignant myositis ossificans. A pathological study of eight cases.

Authors:  R Lagier; J N Cox
Journal:  Hum Pathol       Date:  1975-11       Impact factor: 3.466

2.  Myositis ossificans traumatica of the hand.

Authors:  Manish Chadha; Anil Agarwal
Journal:  Can J Surg       Date:  2007-12       Impact factor: 2.089

3.  Myositis ossificans: a serious complication of a minor injury.

Authors:  J M Ryan
Journal:  CJEM       Date:  1999-10       Impact factor: 2.410

Review 4.  Quadriceps contusions. West Point update.

Authors:  J B Ryan; J H Wheeler; W J Hopkinson; R A Arciero; K R Kolakowski
Journal:  Am J Sports Med       Date:  1991 May-Jun       Impact factor: 6.202

Review 5.  Post-traumatic ectopic calcification in the muscles of athletes: a review.

Authors:  J B King
Journal:  Br J Sports Med       Date:  1998-12       Impact factor: 13.800

6.  Myositis ossificans circumscripta without history of trauma.

Authors:  Jose Aneiros-Fernandez; Mercedes Caba-Molina; Salvador Arias-Santiago; Francisco Ovalle; Pedro Hernandez-Cortes; Jose Aneiros-Cachaza
Journal:  J Clin Med Res       Date:  2010-05-19

7.  Treatment of traumatic myositis ossificans with acetic acid iontophoresis.

Authors:  D L Wieder
Journal:  Phys Ther       Date:  1992-02

8.  Quadriceps Hematoma. A prospective clinical study.

Authors:  A G Rothwell
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

9.  Myositis ossificans of the upper extremity: a long-term follow-up.

Authors:  W O Carlson; R A Klassen
Journal:  J Pediatr Orthop       Date:  1984-11       Impact factor: 2.324

10.  Post-traumatic myositis ossificans of the sternocleidomastoid following fracture of the clavicle: a case report.

Authors:  Shelain Patel; Andrew Richards; Ravi Trehan; Gil T Railton
Journal:  Cases J       Date:  2008-12-22
  10 in total
  4 in total

1.  Myositis ossificans of the longus coli muscle following cervical spine fracture-dislocation.

Authors:  Brandon L Raudenbush; Daren McCalla; Addisu Mesfin; Paul T Rubery
Journal:  J Spinal Cord Med       Date:  2016-03-09       Impact factor: 1.985

2.  Myositis ossificans revisited - The largest reported case series.

Authors:  A Saad; C Azzopardi; A Patel; A M Davies; R Botchu
Journal:  J Clin Orthop Trauma       Date:  2021-03-13

3.  Total Ankylosis by Heterotopic Ossification in an Adolescent Anterior Trans-olecranon Fracture Dislocation: A Case Report.

Authors:  Beom-Soo Kim; Kwang-Soon Song; Ki-Cheor Bae; Si-Wook Lee; Sang-Hyun Um; Chul-Hyun Cho
Journal:  Clin Shoulder Elb       Date:  2019-09-01

4.  Myositis ossificans of the thigh causing external compression of the superficial femoral artery and vein: A case report.

Authors:  Sung Il Wang; Eun Hae Park; Hong Pil Hwang; Jung Ryul Kim
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.